July 7, 2020

Glytec and ThunderCat Technology Partner to Improve Glycemic Management at VA Hospitals

Glytec and ThunderCat Technology Partner to Improve Glycemic Management at VA Hospitals Collaboration Seeks to Improve Outcomes and Reduce Cost of Care for the 25% of Veterans with Diabetes WALTHAM, MASS. (July 7, 2020) – Glytec, the only provider of insulin management software across the continuum of care, and ThunderCat Technology, a Service-Disabled Veteran-Owned Small Business (SDVOSB) that delivers technology …

Read More

June 16, 2020

5 Reasons Why Providers Need Electronic Support for Glycemic Management

JUNE 2020 ROBBY BOOTH 5 Reasons Why Providers Need Electronic Support for Glycemic Management It’s no secret hyperglycemia and hypoglycemia are associated with adverse outcomes in hospitalized patients. We’ve known for many years that hyperglycemia is widespread in the hospital, causes immune dysfunction, higher rates of infection, a longer length of hospital stay, complications, and even death. Insulin has been …

Read More

June 15, 2020

Bruce Bode, MD: Impact of COVID-19 on Diabetes Care and Endocrinology

JUNE 2020 PATRICK CAMPBELL Bruce Bode, MD: Impact of COVID-19 on Diabetes Care and Endocrinology The impact of the coronavirus disease 2019 (COVID-19) outbreak on endocrinology has been impossible to ignore. With diabetic patients at increased risk of developing serious complications, endocrinologists have had to keep a keen eye on the latest on the disease for the wellbeing of their …

Read More

Onduo, Medtronic, Abbott, Glytec present diabetes management study data at ADA 2020 virtual conference

JUNE 2020 DAVE MUOIO Onduo, Medtronic, Abbott, Glytec present diabetes management study data at ADA 2020 virtual conference From virtual management programs to hybrid closed loop systems, diabetes management companies put the spotlight on improved blood glucose management and positive clinical outcomes. The American Diabetes Association’s 80th Scientific Sessions kicked off this weekend, and a handful of diabetes management device-makers …

Read More

Glytec’s Glucommander Software Combined with Continuous Glucose Monitoring Enables Patients with Diabetes to Improve Time in Range by More than 25% in Only Four Weeks

Glytec’s Glucommander Software Combined with Continuous Glucose Monitoring Enables Patients with Diabetes to Improve Time in Range by More than 25% in Only Four Weeks First study to utilize CGM data with FDA-cleared, cloud-based titration software suggests significantly improved outcomes for patients while optimizing clinical resources WALTHAM, MASS. (June 16, 2020) – Glytec, the only provider of insulin management software across …

Read More

June 13, 2020

Preventing Hypoglycemia, Hyperglycemia with Insulin and Glucagon Coadministration

JUNE 2020 PATRICK CAMPBELL Preventing Hypoglycemia, Hyperglycemia with Insulin and Glucagon Coadministration Attempting to prevent hypoglycemia without worsening hyperglycemia in those with type 1 diabetes has been a challenge for clinicians for decades, but results of a new study from the American Diabetes Association’s (ADA) 80th Scientific Sessions signal there could be a change on the horizon. Results of the 11-person proof-of-concept trial …

Read More

June 11, 2020

Healthcare Providers Showcase Value of Glytec’s Insulin Management Software During Diabetes Technology Society’s Virtual Hospital Poster Session

Healthcare Providers Showcase Value of Glytec’s Insulin Management Software During Diabetes Technology Society’s Virtual Hospital Poster Session Event Includes Six Studies on Quality and Cost Improvements Achieved Through Glytec eGMS® WALTHAM, MASS. (June 11, 2020) – Glytec, the only provider of insulin management software across the continuum of care, announced today that healthcare providers from five separate health systems will present studies …

Read More

June 4, 2020

Pandemic Parallels: Glycemic Control in COVID-19 Patients

MAY 2020 DEREK BAGLEY Pandemic Parallels: Glycemic Control in COVID-19 Patients As the COVID-19 pandemic continues to roil the world’s healthcare systems, endocrinologists may have unique insights that could save lives and improve outcomes in these patients who present with elevated glucose levels and other underlying comorbidities such as obesity and diabetes. At a Glance Patients with diabetes who contract …

Read More

April 27, 2020

Uncontrolled hyperglycemia might be COVID-19 mortality risk factor

APRIL 27, 2020 Eleanor McDermid Uncontrolled hyperglycemia might be COVID-19 mortality risk factor medwireNews: A descriptive analysis of US patients with COVID-19 reports a high in-hospital mortality rate in those with uncontrolled hyperglycemia. The rate was markedly higher than that seen in patients with confirmed diabetes, although Valerie Garrett (Glytec Inc., Waltham, Massachusetts, USA) and co-researchers note that they did …

Read More

COVID-19 death rates ‘four times higher’ among those with diabetes and hyperglycemia

APRIL 27, 2020 Mike Watts COVID-19 death rates ‘four times higher’ among those with diabetes and hyperglycemia Hospital teams are being urged to focus on glycemic management among COVID-19 patients with diabetes and hyperglycemia after a research team found mortality rates are higher in people with diabetes. An American team from the Emory University School of Medicine in Georgia say death rates are …

Read More
Page 1 of 14
1 2 3 4 … 14